Epilepsy: Epidemiology, Molecular Pathogenesis, and Clinical Management
Jian Liu, Xinyan Wu, Ting Yin, Feining Huang, Manqi Kong, Yu Yang, Zinan Liu, Jiabin Yu, Tianpeng Zhang · 2026
Read Epilepsy: Epidemiology, Molecular Pathogenesis, and Clinical Management by Jian Liu, Xinyan Wu, Ting Yin, Feining Huang, Manqi Kong, Yu Yang, Zinan Liu, Jiabin Yu, Tianpeng Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13319420.txt.
Description
Jian Liu and co-authors give a broad review of epilepsy in a 2026 article on causes, body changes, and care. The seizure illness affects more than 50 million people worldwide and adds to early death and long term hardship. Near one third of patients still have seizures despite drug care, which shows how much remains unclear about how seizures start.
Gene faults, faulty cell signals, swelling in brain tissue, energy strain, and shifts in cell control are traced as paths that leave brain circuits prone to fire too much. Care now spans exact gene tests, surgery, implanted devices, diet plans, and timed dosing. New gene and immune based methods aim to change the illness itself, not just calm seizures.
Catalog record
| CREATOR | Jian Liu, Xinyan Wu, Ting Yin, Feining Huang, Manqi Kong, Yu Yang, Zinan Liu, Jiabin Yu, Tianpeng Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 146845 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |